Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: A randomized clinical trial
✍ Scribed by Mathurin, Philippe (author);Louvet, Alexandre (author);Duhamel, Alain (author);Nahon, Pierre (author);Carbonell, Nicolas (author);Boursier, Jérôme (author);Anty, Rodolphe (author);Diaz, Emmanuel (author);Thabut, Dominique (author);Moirand, Romain (author);Lebrec, Didier (author);Moreno, Christophe (author);Talbodec, Nathalie (author);Paupard, Thierry (author);Naveau, Sylvie (author);Silvain, Christine (author);Pageaux, Georges Philippe (author);Sobesky, Rodolphe (author);Canva-Delcambre, Valérie (author);Dharancy, Sébastien (author);Salleron, Julia (author);Dao, Thong (author)
- Book ID
- 121077315
- Publisher
- American Medical Association
- Year
- 2013
- Tongue
- English
- Weight
- 434 KB
- Volume
- 310
- Category
- Article
- ISSN
- 0098-7484
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
for the Foie-Alcool group of the Association Franc ¸aise pour l'Etude du Foie (AFEF)\*\* Tumor necrosis factor-␣ (TNF-␣) may contribute to the progression of acute alcoholic hepatitis (AAH). The aim of this study was to evaluate the efficacy of an association of infliximab and prednisolone at reduci